Blijham GH - Search Results

1

Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.

Los M, Aarsman CJ, Terpstra L, Wittebol-Post D, Lips CJ, Blijham GH, Voest EE. Los M, et al. Among authors: blijham gh. Ann Oncol. 1997 Oct;8(10):1015-22. doi: 10.1023/a:1008213320642. Ann Oncol. 1997. PMID: 9402176 Free article. Clinical Trial.

2

Expression pattern of the von Hippel-Lindau protein in human tissues.

Los M, Jansen GH, Kaelin WG, Lips CJ, Blijham GH, Voest EE. Los M, et al. Among authors: blijham gh. Lab Invest. 1996 Aug;75(2):231-8. Lab Invest. 1996. PMID: 8765323

3

Distress in MEN 2 family members and partners prior to DNA test disclosure. Multiple endocrine neoplasia type 2.

Grosfeld FJ, Lips CJ, Beemer FA, Blijham GH, Quirijnen JM, Mastenbroek MP, ten Kroode HF. Grosfeld FJ, et al. Among authors: blijham gh. Am J Med Genet. 2000 Mar 6;91(1):1-7. doi: 10.1002/(sici)1096-8628(20000306)91:1<1::aid-ajmg1>3.0.co;2-9. Am J Med Genet. 2000. PMID: 10751081

4

From medical history and biochemical tests to presymptomatic treatment in a large MEN 2A family.

Lips CJ, Landsvater RM, Höppener JW, Geerdink RA, Blijham GH, Jansen-Schillhorn van Veen JM, Feldberg MA, van Gils AP, Hoogenboom H, Berends MJ, et al. Lips CJ, et al. Among authors: blijham gh. J Intern Med. 1995 Oct;238(4):347-56. doi: 10.1111/j.1365-2796.1995.tb01209.x. J Intern Med. 1995. PMID: 7595171

5

Clinical research on antiangiogenic therapy.

Kuiper RA, Schellens JH, Blijham GH, Beijnen JH, Voest EE. Kuiper RA, et al. Among authors: blijham gh. Pharmacol Res. 1998 Jan;37(1):1-16. doi: 10.1006/phrs.1997.0268. Pharmacol Res. 1998. PMID: 9503474 Review.

6

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.

Lips CJ, Landsvater RM, Höppener JW, Geerdink RA, Blijham G, van Veen JM, van Gils AP, de Wit MJ, Zewald RA, Berends MJ, et al. Lips CJ, et al. N Engl J Med. 1994 Sep 29;331(13):828-35. doi: 10.1056/NEJM199409293311302. N Engl J Med. 1994. PMID: 7915822 Free article.

7

Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.

Moers AM, Landsvater RM, Schaap C, Jansen-Schillhorn van Veen JM, de Valk IA, Blijham GH, Höppener JW, Vroom TM, van Amstel HK, Lips CJ. Moers AM, et al. Among authors: blijham gh. Am J Med. 1996 Dec;101(6):635-41. doi: 10.1016/s0002-9343(96)00330-0. Am J Med. 1996. PMID: 9003111

8

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer.

Lalisang RI, Voest EE, Wils JA, Nortier JW, Erdkamp FL, Hillen HF, Wals J, Schouten HC, Blijham GH. Lalisang RI, et al. Among authors: blijham gh. Br J Cancer. 2000 Jun;82(12):1914-9. doi: 10.1054/bjoc.2000.1202. Br J Cancer. 2000. PMID: 10864197 Free PMC article. Clinical Trial.

9

Microvessel density and outcome of adjuvant treatment of breast cancer patients.

Voest EE, Blijham GH. Voest EE, et al. Among authors: blijham gh. Cancer J Sci Am. 1997 May-Jun;3(3):184-5. Cancer J Sci Am. 1997. PMID: 9161785 No abstract available.

10

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.

Lalisang RI, Erdkamp FL, Rodenburg CJ, Knibbeler-van Rossum CT, Nortier JW, van Bochove A, Slee PH, Voest EE, Wils JA, Wals J, Loosveld OJ, Smals AE, Blijham GH, Tjan-Heijnen VC, Schouten HC. Lalisang RI, et al. Among authors: blijham gh. Breast Cancer Res Treat. 2011 Jul;128(2):437-45. doi: 10.1007/s10549-011-1558-3. Epub 2011 May 17. Breast Cancer Res Treat. 2011. PMID: 21584666 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters